Otsuka Pharmaceutical Co. Ltd. is set to expand its neurological pipeline through the acquisition of Canadian firm Mindset Pharma, Inc. CAD8m ($6m).
Since 2022, the Toronto-based firm has been collaborating with the Japanese company’s affiliate to develop a new class of agonists...
Welcome to Scrip
Create an account to read this article
Already a subscriber?